Your browser doesn't support javascript.
loading
Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report.
Mousa, Ahmed H; Ibrahim, Abdullatif S; Alsayed, Abdelrahman Waleed; Albukhari, Zain Z; Mogharbel, Ajfan; Alshanberi, Asim M; Albar, Nezar Y.
Affiliation
  • Mousa AH; College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia.
  • Ibrahim AS; College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia.
  • Alsayed AW; College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia.
  • Albukhari ZZ; College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia.
  • Mogharbel A; Ibn Siena National College, Medicine and Surgery.
  • Alshanberi AM; College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia.
  • Albar NY; Department of Community Medicine and Pilgrims Health Care, Umm Al-Qura University, Makkah.
Ann Med Surg (Lond) ; 85(6): 3012-3016, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37363471
ABSTRACT
Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Case presentation Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. Clinical

discussion:

The surgical cytoreduction or 'debulking' technique is the main treatment option started in individuals with High Grade Serous Ovarian CanceR. This surgical strategy aims to completely remove all disseminated tumor masses that are present in the patient's peritoneal cavity on a macroscopic level.

Conclusion:

In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago.Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Med Surg (Lond) Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Med Surg (Lond) Year: 2023 Document type: Article Affiliation country:
...